Please use this identifier to cite or link to this item:
Title: 3,4-Diaminopyridine and choline increase in vivo acetylcholine release in rat striatum
Authors: Uludağ Üniversitesi/Tıp Fakültesi/Farmakoloji Anabilim Dalı.
Büyükuysal, R. Levent
Ulus, İsmail Hakkı
Sami, Aydın
Kiran, Burhan K.
Keywords: Acetylcholine
Transmitter release
Potassium channels
Corpus striatum
Invivo release
Pharmacology & pharmacy
Issue Date: 13-Apr-1995
Publisher: Elsevier Science BV
Citation: Büyükuysal, R. L. vd. (1995). ''3,4-Diaminopyridine and choline increase in vivo acetylcholine release in rat striatum''. European Journal of Pharmacology, 281(2), 179-185.
Abstract: We investigated the effects of choline, 3,4-diaminopyridine and their combination on acetylcholine release from the corpus striatum of freely moving rats which were treated or not with atropine. Intraperitoneal administration of choline or intrastriatal administration of 3,4-diaminopyridine increased acetylcholine levels in striatal dialysates in a dose-dependent manner. When 3,4-diaminopyridine treatment was combined with choline, the observed effect was considerably greater than the sum of the increases produced by choline or 3,4-diaminopyridine alone. Administration of atropine (1 mu M) in the dialysing medium was also found to be effective to stimulate striatal acetylcholine levels. 3,4-Diaminopyridine did not affect acetylcholine levels under these conditions. Whereas the choline-induced increase in acetylcholine release was significantly potentiated by atropine, co-administration of 3,4-diaminopyridine with choline failed to produce a further significant increase in the presence of atropine. These results suggest that a highly effective means for increasing acetylcholine release involves two concurrent treatments that increase neuronal choline levels and inhibition of the negative feedback modulation of acetylcholine release.
ISSN: 0014-2999
Appears in Collections:Web of Science

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.